Insider · CIK 0001753037
5AM Ventures VI, L.P.
Files at ELVN (Enliven Therapeutics, Inc.), CAMP (Camp4 Therapeutics Corp), LTGO (Latigo Biotherapeutics, Inc.). First filing -, latest -.
In brief
5AM Ventures VI, L.P. files SEC Form 4 as 10% owner at ELVN (Enliven Therapeutics, Inc.), and also at CAMP (Camp4 Therapeutics Corp), LTGO (Latigo Biotherapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; 5AM Ventures VI, L.P. has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | CConversion Common Stockindirect: By 5AM Ventures VI, L.P. | +4,975,543 | - | - | 4,975,543 | Aug 12, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | CConversion Common Stockindirect: By 5AM Opportunities II, L.P. | +2,350,419 | - | - | 2,350,419 | Aug 12, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | CConversion Series A Preferred Stockderivativeindirect: By 5AM Ventures VI, L.P. | -3,152,305 | $0.00 | $0 | 0 | Aug 12, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | CConversion Series A-2 Preferred Stockderivativeindirect: By 5AM Ventures VI, L.P. | -1,823,238 | $0.00 | $0 | 0 | Aug 12, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | CConversion Series A-2 Preferred Stockderivativeindirect: By 5AM Opportunities II, L.P. | -866,018 | $0.00 | $0 | 0 | Aug 12, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | CConversion Series B Preferred Stockderivativeindirect: By 5AM Opportunities II, L.P. | -1,484,401 | $0.00 | $0 | 0 | Aug 12, 2026 |
Questions about 5AM Ventures VI, L.P.
Answered from the filings on this page, as of the latest one.
Is 5AM Ventures VI, L.P. buying or selling?
5AM Ventures VI, L.P. has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did 5AM Ventures VI, L.P.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and 5AM Ventures VI, L.P. has 0.
Where does 5AM Ventures VI, L.P. file Form 4?
5AM Ventures VI, L.P. has filed Form 4 at ELVN (Enliven Therapeutics, Inc.); CAMP (Camp4 Therapeutics Corp); LTGO (Latigo Biotherapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.